Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2006, Cancer Epidemiology, Biomarkers & Prevention
…
3 pages
1 file
Osteosarcoma is a rare malignancy of largely unknown etiology. Although there is no consistent evidence for an association between fluoridation and cancer, some concerns remain about osteosarcoma. As part of the design of a collaborative study, bone samples were collected to allow for an evaluation of the association between osteosarcoma risk and individual fluoride exposure measured by levels of fluoride in bone. In this report, we provide the results of pilot experiments to consider issues that arose during the study design and to assess the reliability of the bone assays. Correlations of fluoride levels between normal bone near the affected area and iliac crest bone were strong and positive. The day-to-day laboratory analysis of fluoride in human and deer jaw bone yielded acceptable average coefficients of variation below 10% and an overall estimate of 5%. The intraclass correlation (ICC) is of particular importance to epidemiologists because it indicates the effect of measuremen...
Journal of Dental Research, 2011
The association between fluoride and risk for osteosarcoma is controversial. The purpose of this study was to determine if bone fluoride levels are higher in individuals with osteosarcoma. Incident cases of osteosarcoma (N = 137) and tumor controls (N = 51) were identified by orthopedic physicians, and segments of tumor-adjacent bone and iliac crest bone were analyzed for fluoride content. Logistic regression adjusted for age and sex and potential confounders of osteosarcoma was used to estimate odds ratios (OR) and 95% confidence intervals (CI). There was no significant difference in bone fluoride levels between cases and controls. The OR adjusted for age, gender, and a history of broken bones was 1.33 (95% CI: 0.56-3.15). No significant association between bone fluoride levels and osteosarcoma risk was detected in our case-control study, based on controls with other tumor diagnoses.
American Journal of Public Health, 1995
International Journal of Epidemiology, 2014
Background: Artificial fluoridation of drinking water to improve dental health has long been a topic of controversy. Opponents of this public health measure have cited the possibility of bone cancer induction. The study objective was to examine whether increased risk of primary bone cancer was associated with living in areas with higher concentrations of fluoride in drinking water. Methods: Case data on osteosarcoma and Ewing sarcoma, diagnosed at ages 0-49 years in Great Britain (GB) (defined here as England, Scotland and Wales) during the period 1980-2005, were obtained from population-based cancer registries. Data on fluoride levels in drinking water in England and Wales were accessed through regional water companies and the Drinking Water Inspectorate. Scottish Water provided data for Scotland. Negative binomial regression was used to examine the relationship between incidence rates and level of fluoride in drinking water at small area level. Results: The study analysed 2566 osteosarcoma and 1650 Ewing sarcoma cases. There was no evidence of an association between osteosarcoma risk and fluoride in drinking water [relative risk (RR) per one part per million increase in the level of fluoride ¼ 1Á001; 90% confidence interval (CI) 0Á871, 1Á151] and similarly there was no association for Ewing sarcoma (RR ¼ 0Á929; 90% CI 0Á773, 1Á115).
Forensic Science International, 2003
The use of bone as a biomarker for chronic and acute exposure to fluoride salts has been suggested, but there are no data published about its use to evaluate lethal intoxication. One hundred and sixty rats were divided into eight groups that received a single oral intubation dose from 0 (control) to 90 mg F/kg as NaF. The animals' time of death was recorded and their femurs were removed for fluoride analysis. Acid-soluble fluoride was determined in the whole bone and on the surface (periosteal), using an ion specific electrode. The data showed a statistically significant relationship between fluoride dose and the number of deaths (P < 0:0001). A statistically significant relationship was also found between fluoride dose and fluoride concentration ([F]) in either the whole femur (P < 0:0017), on the surface (P < 0:0001) or for the ratio periosteal [F]/whole [F] (P < 0:0001). However, the [F] on the femur surface was more closely correlated with mortality than that in the whole bone, showing statistically significant differences among the lethal doses and control (P < 0:05). The data suggest that the ratio [F] periosteal bone/[F] whole bone, is a biomarker for acute fluoride toxicity. #
Social Science Research Network, 2023
The time dependent accumulation of fluoride into bone is estimated over several decades of consuming water treated with synthetic fluoride compounds used in water fluoridation. This is made possible because fluoridated water levels provided to consumers is tightly regulated, and other required quantities are known, including the percentage of fluoride that accumulates in bone after ingestion, the average adult bone mass, and daily water consumption. Fluoride bone accumulation in those who faithfully consume the treated water daily suggests that cases of stage II skeletal fluorosis associated with its arthritic symptoms may be widespread in the U.S. Introduction. Direct measurements of the fluoride content of bone from deceased individuals at autopsy were conducted by Zipkin in 1958 [1]. During lifelong consumption of water containing natural calcium fluoride, fluoride ion accumulates in bone hydroxyapatite by ion exchange with hydroxide as a function of time in a manner that is not biochemically reversible [2,3] and continues to accumulate as long as fluoride water is ingested throughout life. In the U.S., water 'fluoridation' with unnatural, industrial fluoride compounds has become widespread and is actually recommended by the dental division of the U.S. Centers for Disease Control and Prevention (CDCP), by officials at the U.S. Environmental Protection Agency (EPA), and is recently even promoted by factions in the U.S. National Institutes of Health (NIH). Meanwhile, the U.S. Food and Drug Administration (FDA) has never approved fluoride for ingestion due to lack of controlled clinical trials historically, ruled that fluoride is not considered safe to add to foods, that its addition into public water supplies would be an uncontrolled use of an unapproved drug, that fluoride should not be administered to pregnant women, and that synthetic fluorides should be regulated under the Toxic Substances Control Act and the Federal Insecticide, Fungicide, and Rodenticide Act [6,7,8,9,10]. Estimates of fluoride accumulation in bone of populations treated with water intentionally infused with fluoride from synthetic sources is sorely needed for four important reasons. First, the EPA has not revised the allowed maximum contaminant level (MCL) for fluoride after the National Research Council (NRC) reported for the EPA that current allowed levels are not protective of health [2, 4]. Second, the MCL was set originally merely to prevent consumers from developing crippling skeletal fluorosis that ignored other bone pathology understood now to occur at lower levels. Third, the MCL was developed based on data
Journal of Analytical Toxicology, 2005
This study compares fluoride concentrations ([F]) in surface and whole bone for up to 27 days following an acute oral dose of F. Four groups of rats received single oral F dose (50 mg/kg body weight), and the control group received deionized water (n = 10/group). Groups were eutbanized at 1, 3, 9, or 27 days after F administration. Plasma and femurs were collected. F on the femur surface was removed from a circular area (4.52 mm 2) by immersion in 0.5M HCI for 15 s. The solution was buffered with total ionic strength adjustment buffer and analyzed with an electrode. The subjacent bone was sectioned and ashed at 600~ Ash and plasma were analyzed for F with the electrode following hexamethyldisiloxane-facilitated diffusion. Data were analyzed by KruskalI-Wallis and Dunn's test and by linear regression (p < 0.05). Peak plasma and bone surface [F] occurred on day 1 (0.26 _+ 0.14 pg/mL and 1801 _+ 888 pg/g, respectively). Bone surface [F] at 3, 9, and 27 were not statistically different from control. A significant increase in whole bone IF] was observed 3 days after F administration and the [F] remained relatively constant thereafter. The mean (_+ SD) surface/whole bone [F] ratios for the control and F groups were 2.45 _+ 0.98, 3.92 _+ 1.32, 1.61 _ 0.82, 1.73 _+ 0.39, and 1.09 _+ 0.28, respectively. Plasma and bone surface [F]s were positively correlated (r-0.74). Thus, bone surface was found to be a suitable biomarker for acute, sublethal F exposure 1 day after F administration. Whole bone [F] were significantly increased at 3, 9, and 27 days after F administration.
Calcified Tissue International, 1995
The aim of this work was to explore the reduction of fluoride concentrations in the skeleton after stopping experimental fluoride administration. Fluoride was administered to the rats at varying doses (0, 50, 100 ppm in drinking water) and for different lengths of time (4, 13, 25 weeks). A series of fluoride concentrations across the full thickness of humerus, parietal bone, and vertebra arch in rats were measured by means of an abrasive micro-sampling technique. The distribution profiles of fluoride from periosteal to endosteal surfaces, which were apparently related to the histological structure of these bones, were U shaped in the humerus, V shaped in the parietal bone, and W shaped in the vertebra arch. The average fluoride concentrations in the bones increased significantly with each increasing dose and length of fluoride administration. The relative increments were similar between the different regions or the different bones. After stopping fluoride administration, on the other hand, the relative reduction of the average fluoride concentrations in the bones were 30-100%. They were greatly related to the length after stopping fluoride administration and the dose and length of fluoride administration, but also dependent upon the type of bone and the region examined.
International Journal of Applied Radiation and Isotopes, 1977
Ther fluorine concentration in bone biopsy samples was measured by neutron activation analysis. The fluorine content was expressed in terms of the calcium content. Samples were irradiated in a reactor to induce the 1eF(n,y)2oF and a8Ca1n,y)aeCa reactions and after rapid transport from the reactor the resulting activities were measured with a Ge(Li) detector. Reproducibility was better than 10/" ior the F/Ca ratio. The detection limit for F is 50 pg. This nondestructive technique will be used to assess the effect of fluoride therapy on bone metabolism of patients with idiopathic osteoporosis.
Liturgia sacra, 2022
Linguistics, 2000
American Journal of Advanced Drug Delivery, 2014
Kanyú, 2024
Physica Scripta, 2024
Arte, Individuo y Sociedad, Ediciones complutense, 2020
SN Comprehensive Clinical Medicine, 2022
Obstetric Medicine, 2018
Economic Geology, 1998
35. Велицко В.В. Тепло – жизнь города, а его отсутствие… // Коммунальщик, №9, 2015 г., С.30–37, 2015
Águas Subterrâneas, 2005
Analisa: Journal of Social Science and Religion, 2018
Polymer Chemistry, 2017
Enciclopédia Biosfera, 2021
‘O que é que você quer ser? carroceiro?’: A labuta dos trabalhadores do transporte em Salvador no século XIX - Mona Lisa Nunes , 2024